
Innoplexus helps life sciences organizations accelerate drug discovery and development by turning vast biomedical data into actionable insights. It does this via AI- and ML-driven platforms—notably the Ontosight® Platform and the Amrit Ecosystem—that aggregate and analyze publications, clinical trials, patents, and biomedical terms using technologies such as life-science language processing, computer vision, federated learning, blockchain, and smart contracts. The company offers these capabilities as SaaS/Data-as-a-Service and Continuous Analytics services for pharmaceutical, biotech, CRO, hospital, and lab customers. Innoplexus operates globally and targets enterprises seeking to shorten development timelines, improve therapeutic strategies, and support decentralized science workflows.

Innoplexus helps life sciences organizations accelerate drug discovery and development by turning vast biomedical data into actionable insights. It does this via AI- and ML-driven platforms—notably the Ontosight® Platform and the Amrit Ecosystem—that aggregate and analyze publications, clinical trials, patents, and biomedical terms using technologies such as life-science language processing, computer vision, federated learning, blockchain, and smart contracts. The company offers these capabilities as SaaS/Data-as-a-Service and Continuous Analytics services for pharmaceutical, biotech, CRO, hospital, and lab customers. Innoplexus operates globally and targets enterprises seeking to shorten development timelines, improve therapeutic strategies, and support decentralized science workflows.